Membrane fluidity effects of estratrienes

Yuan Liang, Shana Belford, Fuxing Tang, Laszlo Prokai, James W. Simpkins, Jeffrey A. Hughes

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Estrogens have demonstrable neuroprotective effects. This fact has lead to the proposed use of estrogens for the prevention and/or treatment of Alzheimer's disease. The exact protective mechanism estrogens provide is not fully understood. In this report, a potential non-genomic mechanism for estratrienes involving alterations in membrane fluidity was studied. Steroids, such as estrogen, are known to be membrane-active and can alter the lipid packing. In this study we used fluorescent methodologies to address the effect of naturally occurring steroids (17α and 17β-estradiol, testosterone, and progesterone) and new estratriene analogs on membrane fluidity using liposomes and HT-22 hippocampal cells. The study's results indicate steroids, based on the estratriene nucleus, can modulate lipid packing as evidenced by (1) decreased membrane fusion events and (2) decreased membrane fluidity. The effects on the membrane were both time and concentration dependent. It was also demonstrated through rational design estratriene analogs can be synthesized with enhanced membrane effects. Finally, in a glutamate-induced toxicity HT-22 model, we also demonstrated cellular protection with the estratriene-based molecules and analogs. The data suggest the plethora of cellular actions of estrogens may relate to or be influenced by membrane effects of the steroid.

Original languageEnglish
Pages (from-to)661-668
Number of pages8
JournalBrain Research Bulletin
Volume54
Issue number6
DOIs
StatePublished - 19 Jun 2001

Fingerprint

Membrane Fluidity
Estrogens
Steroids
Membranes
Lipids
Membrane Fusion
Neuroprotective Agents
Liposomes
Progesterone
Testosterone
Glutamic Acid
Estradiol
Alzheimer Disease

Keywords

  • Alzheimer's
  • Estrogens
  • Fluidity
  • Liposomes

Cite this

Liang, Y., Belford, S., Tang, F., Prokai, L., Simpkins, J. W., & Hughes, J. A. (2001). Membrane fluidity effects of estratrienes. Brain Research Bulletin, 54(6), 661-668. https://doi.org/10.1016/S0361-9230(01)00483-X
Liang, Yuan ; Belford, Shana ; Tang, Fuxing ; Prokai, Laszlo ; Simpkins, James W. ; Hughes, Jeffrey A. / Membrane fluidity effects of estratrienes. In: Brain Research Bulletin. 2001 ; Vol. 54, No. 6. pp. 661-668.
@article{3f199de5a7f14b61829a4003f3152f8f,
title = "Membrane fluidity effects of estratrienes",
abstract = "Estrogens have demonstrable neuroprotective effects. This fact has lead to the proposed use of estrogens for the prevention and/or treatment of Alzheimer's disease. The exact protective mechanism estrogens provide is not fully understood. In this report, a potential non-genomic mechanism for estratrienes involving alterations in membrane fluidity was studied. Steroids, such as estrogen, are known to be membrane-active and can alter the lipid packing. In this study we used fluorescent methodologies to address the effect of naturally occurring steroids (17α and 17β-estradiol, testosterone, and progesterone) and new estratriene analogs on membrane fluidity using liposomes and HT-22 hippocampal cells. The study's results indicate steroids, based on the estratriene nucleus, can modulate lipid packing as evidenced by (1) decreased membrane fusion events and (2) decreased membrane fluidity. The effects on the membrane were both time and concentration dependent. It was also demonstrated through rational design estratriene analogs can be synthesized with enhanced membrane effects. Finally, in a glutamate-induced toxicity HT-22 model, we also demonstrated cellular protection with the estratriene-based molecules and analogs. The data suggest the plethora of cellular actions of estrogens may relate to or be influenced by membrane effects of the steroid.",
keywords = "Alzheimer's, Estrogens, Fluidity, Liposomes",
author = "Yuan Liang and Shana Belford and Fuxing Tang and Laszlo Prokai and Simpkins, {James W.} and Hughes, {Jeffrey A.}",
year = "2001",
month = "6",
day = "19",
doi = "10.1016/S0361-9230(01)00483-X",
language = "English",
volume = "54",
pages = "661--668",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "6",

}

Liang, Y, Belford, S, Tang, F, Prokai, L, Simpkins, JW & Hughes, JA 2001, 'Membrane fluidity effects of estratrienes', Brain Research Bulletin, vol. 54, no. 6, pp. 661-668. https://doi.org/10.1016/S0361-9230(01)00483-X

Membrane fluidity effects of estratrienes. / Liang, Yuan; Belford, Shana; Tang, Fuxing; Prokai, Laszlo; Simpkins, James W.; Hughes, Jeffrey A.

In: Brain Research Bulletin, Vol. 54, No. 6, 19.06.2001, p. 661-668.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Membrane fluidity effects of estratrienes

AU - Liang, Yuan

AU - Belford, Shana

AU - Tang, Fuxing

AU - Prokai, Laszlo

AU - Simpkins, James W.

AU - Hughes, Jeffrey A.

PY - 2001/6/19

Y1 - 2001/6/19

N2 - Estrogens have demonstrable neuroprotective effects. This fact has lead to the proposed use of estrogens for the prevention and/or treatment of Alzheimer's disease. The exact protective mechanism estrogens provide is not fully understood. In this report, a potential non-genomic mechanism for estratrienes involving alterations in membrane fluidity was studied. Steroids, such as estrogen, are known to be membrane-active and can alter the lipid packing. In this study we used fluorescent methodologies to address the effect of naturally occurring steroids (17α and 17β-estradiol, testosterone, and progesterone) and new estratriene analogs on membrane fluidity using liposomes and HT-22 hippocampal cells. The study's results indicate steroids, based on the estratriene nucleus, can modulate lipid packing as evidenced by (1) decreased membrane fusion events and (2) decreased membrane fluidity. The effects on the membrane were both time and concentration dependent. It was also demonstrated through rational design estratriene analogs can be synthesized with enhanced membrane effects. Finally, in a glutamate-induced toxicity HT-22 model, we also demonstrated cellular protection with the estratriene-based molecules and analogs. The data suggest the plethora of cellular actions of estrogens may relate to or be influenced by membrane effects of the steroid.

AB - Estrogens have demonstrable neuroprotective effects. This fact has lead to the proposed use of estrogens for the prevention and/or treatment of Alzheimer's disease. The exact protective mechanism estrogens provide is not fully understood. In this report, a potential non-genomic mechanism for estratrienes involving alterations in membrane fluidity was studied. Steroids, such as estrogen, are known to be membrane-active and can alter the lipid packing. In this study we used fluorescent methodologies to address the effect of naturally occurring steroids (17α and 17β-estradiol, testosterone, and progesterone) and new estratriene analogs on membrane fluidity using liposomes and HT-22 hippocampal cells. The study's results indicate steroids, based on the estratriene nucleus, can modulate lipid packing as evidenced by (1) decreased membrane fusion events and (2) decreased membrane fluidity. The effects on the membrane were both time and concentration dependent. It was also demonstrated through rational design estratriene analogs can be synthesized with enhanced membrane effects. Finally, in a glutamate-induced toxicity HT-22 model, we also demonstrated cellular protection with the estratriene-based molecules and analogs. The data suggest the plethora of cellular actions of estrogens may relate to or be influenced by membrane effects of the steroid.

KW - Alzheimer's

KW - Estrogens

KW - Fluidity

KW - Liposomes

UR - http://www.scopus.com/inward/record.url?scp=0034982658&partnerID=8YFLogxK

U2 - 10.1016/S0361-9230(01)00483-X

DO - 10.1016/S0361-9230(01)00483-X

M3 - Article

C2 - 11403993

AN - SCOPUS:0034982658

VL - 54

SP - 661

EP - 668

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 6

ER -

Liang Y, Belford S, Tang F, Prokai L, Simpkins JW, Hughes JA. Membrane fluidity effects of estratrienes. Brain Research Bulletin. 2001 Jun 19;54(6):661-668. https://doi.org/10.1016/S0361-9230(01)00483-X